| |
|
|
|
CymaBay Therapeutics Inc.  
|
|
6.22 -0.21 (-0.03%) |
07-19 16:00 |
|
Open: |
6.42 |
Pre close: |
6.43 |
Target:
|
8.15 
|
|
High: |
6.44 |
Low: |
6.18 |
Resistance:
|
6.98
7.49
|
|
Volume: |
473,618 |
Market Cap: |
427M |
Support:
|
6.16
5.12
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.41
 |
MACD |
MACD(12,26):
|
-0.70 |
|
MA(20): |
6.77 |
Signal(12,26,9): |
-0.82 |
|
MA(100): |
11.02 |
Stochastic Oscillator |
%K(14,3):
|
11.65 |
|
MA(250): |
10.59 |
%D(3): |
13.14 |
|
Average Volume(K) |
3-Month: |
138466
|
52-Week |
High:
|
14.00 |
|
10-Days: |
71417 |
Low: |
4.82 |
|
RSI |
RSI(14):
|
31.75 |
Change(%): |
-49.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.320 |
Return on Equity (ttm) |
-33.5 |
Shares Out. (M) |
0.00 |
|
EPS Est. Current Year |
-0.820 |
Return on Assets (ttm) |
-20.7 |
Shares Float (M) |
53.87 |
|
EPS Est. Next Year |
-0.740 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.74 |
|
EPS Est. Next Quarter |
-0.160 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
88.51 |
|
Forward EPS |
-0.940 |
Gross Profit (p.s.) |
-0.637 |
Shares Short (K) |
7460 |
|
Book Value (p.s.) |
3.750 |
EBITDA (p.s.) |
-1.218 |
P/E |
-4.71 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.66 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-70.89 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-49.59 |
P/CF |
-0.00 |
|
|
|
|
|
|
